BOLT   $0.5849  2.47% Market Closed

Bolt Biotherapeutics Inc
Total Cash 73.70M
totalCashPerShare 1.926
EBITDA -72.23M
Total Debt 18.89M
quickRatio 4.128
currentRatio 4.281
Total Revenue 11.17M
debtToEquity 22.002
Revenue/Share 0.294
ROA -0.29406
ROE -0.58042
grossProfits
freeCashflow -33.36M
operatingCashflow -63.91M
earningsGrowth
revenueGrowth -0.11
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -14.92706
profitMargins 0.0
enterpriseValue -29.63M
forwardPE -0.5059375
floatShares 25.04M
sharesOutstanding 38.26M
sharesShort 119.45K
sharesShortPriorMonth 195.60K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.60%
Short Ratio help_outline 0.86%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 2.244
Price To Book help_outline 0.29
earningsQuarterlyGrowth
netIncomeToCommon -66.17M
trailingEps -1.74%
forwardEps -1.28%
enterpriseToEbitda 0.41
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.35 3Q 2024
institutionsCount 41
lastUpdated Nov. 7, 2024, 4:54 a.m.